Literature DB >> 33654054

'nAb' the self-reactive activity in the COVID-19 combat.

Madhusudhanan Narasimhan1, Lenin Mahimainathan1, Alagarraju Muthukumar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33654054      PMCID： PMC7921608          DOI： 10.1038/s41392-021-00518-2

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  4 in total

Review 1.  The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health.

Authors:  Timothy P Sheahan; Matthew B Frieman
Journal:  Curr Opin Virol       Date:  2020-06-04       Impact factor: 7.090

2.  High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.

Authors:  Christiana Franke; Caroline Ferse; Jakob Kreye; S Momsen Reincke; Elisa Sanchez-Sendin; Andrea Rocco; Mirja Steinbrenner; Stefan Angermair; Sascha Treskatsch; Daniel Zickler; Kai-Uwe Eckardt; Rick Dersch; Jonas Hosp; Heinrich J Audebert; Matthias Endres; J Christoph Ploner; Harald Prüß
Journal:  Brain Behav Immun       Date:  2020-12-24       Impact factor: 7.217

3.  A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.

Authors:  Jakob Kreye; S Momsen Reincke; Hans-Christian Kornau; Elisa Sánchez-Sendin; Victor Max Corman; Hejun Liu; Meng Yuan; Nicholas C Wu; Xueyong Zhu; Chang-Chun D Lee; Jakob Trimpert; Markus Höltje; Kristina Dietert; Laura Stöffler; Niels von Wardenburg; Scott van Hoof; Marie A Homeyer; Julius Hoffmann; Azza Abdelgawad; Achim D Gruber; Luca D Bertzbach; Daria Vladimirova; Lucie Y Li; Paula Charlotte Barthel; Karl Skriner; Andreas C Hocke; Stefan Hippenstiel; Martin Witzenrath; Norbert Suttorp; Florian Kurth; Christiana Franke; Matthias Endres; Dietmar Schmitz; Lara Maria Jeworowski; Anja Richter; Marie Luisa Schmidt; Tatjana Schwarz; Marcel Alexander Müller; Christian Drosten; Daniel Wendisch; Leif E Sander; Nikolaus Osterrieder; Ian A Wilson; Harald Prüss
Journal:  Cell       Date:  2020-09-23       Impact factor: 41.582

4.  Do cross-reactive antibodies cause neuropathology in COVID-19?

Authors:  Jakob Kreye; S Momsen Reincke; Harald Prüss
Journal:  Nat Rev Immunol       Date:  2020-11       Impact factor: 53.106
  4 in total
  1 in total

1.  Structural Comparison and Drug Screening of Spike Proteins of Ten SARS-CoV-2 Variants.

Authors:  Qiangzhen Yang; Xuemin Jian; Ali Alamdar Shah Syed; Aamir Fahira; Chenxiang Zheng; Zijia Zhu; Ke Wang; Jinmai Zhang; Yanqin Wen; Zhiqiang Li; Dun Pan; Tingting Lu; Zhuo Wang; Yongyong Shi
Journal:  Research (Wash D C)       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.